[1] Fan JG,Saibara T,Chitturi S,et al. What are the risk factors and settings for nonalcoholic fatty liver disease in Asia- Pacific.Gastroenterol Hepatol,2007,22: 794-800.
[2] Farrell GC, Larter CZ.Nonalcoholic fatty liver disease:from steatosis to cirrhosis.Hepatology,2006,43(2 Suppl 1): S99-S112.
[3] De Alwis NM,Day CP.Non-alcoholic fatty liver disease:the mist gradually clears.J Hepatol,2008,48(Suppl1): S104-S112.
[4] Vuppalanchi R, Chalasani N.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis :Selected practical issues in their evaluation and management.Hepatology,2009,49: 306-317.
[5] Chang BX, Li BS, Zou ZS. An excerpt of EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease(2016). J Clin Hepa,2016, 32: 1450-1454.
[6] Dyson JK,Mcpherson S,Anstee QM. Republished: non-alco-holic fatty liver disease: non-invasive investigation and risk stratification. Postgrad Med J,2014,90: 254-266. |
